PharmGKB Blog
Wednesday, March 25, 2020

New CPIC Guideline: CYP2C9 and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

›
The CPIC Guideline for  CYP2C9  and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)  is now published in  Clinical Pharmacology and Therap...
Monday, March 23, 2020

Lamotrigine pathway published in Pharmacogenetics and Genomics

›
The PharmGKB lamotrigine pathway has been recently published in the journal Pharmacogenetics and Genomics . The publication, written by...
Sunday, February 23, 2020

FDA releases tables on the use of pharmacogenetic testing for specific medications

›
CPIC and PharmGKB applaud the release of additional guidance from the FDA on the use of pharmacogenetic testing for specific medications . ...
Monday, February 10, 2020

Centralized presentation material repository now available from CPIC’s PGx Dissemination working group

›
The CPIC’s PGx Dissemination working group has developed a central repository for pharmacogenomic-related presentation material...
Tuesday, January 21, 2020

PharmGKB and CPIC support H.R. 3235 (updated 1/27/20)

›
PharmGKB and CPIC have signed up as supporters of H.R. 3235 , the ‘Access to Genetic Counselor Services Act’. This bill woul...
1 comment:
Friday, January 17, 2020

PharmGKB papers in the February 2020 issue of Pharmacogenetics and Genomics

›
The February 2020 issue of Pharmacogenetics and Genomics  has a PharmGKB double feature, with the publication of our sertral...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.